RETRACTION: Phenylacetyl Glutamine (PAGln) Enhances Cardiomyocyte Death After Myocardial Infarction Through β1 Adrenergic Receptor.

Abstract

Retraction: H. Xu, N. Yang, B.Y. Wang, L. Zhou, L.L. Xu, Y. Chen, D.J. Wang, and W.H. Ge, "Phenylacetyl Glutamine (PAGln) Enhances Cardiomyocyte Death after Myocardial Infarction through β1 Adrenergic Receptor," Environmental Toxicology 39, no. 3 (2024): 1682-1699, https://doi.org/10.1002/tox.24063. The above article, published online on 02 December 2023, in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor-in-Chief, Paul B. Tchounwou; and Wiley Periodicals LLC. Following an investigation by the publisher, the parties have concluded that this article was accepted solely on the basis of a compromised peer review process. In addition, the investigation found there was significant unattributed textual overlap between this article and a previously-published article (Beale et al., 2008; https://doi.org/10.1186/1471-2407-8-200). Therefore, the article must be retracted. The authors Weihong Ge and Hang Xu disagree with this decision. The other authors did not respond.